Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Current Assets: 2020-2025

Historic Current Assets for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to $237.6 million.

  • GeneDx Holdings' Current Assets rose 27.73% to $237.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $237.6 million, marking a year-over-year increase of 27.73%. This contributed to the annual value of $198.0 million for FY2024, which is 8.57% up from last year.
  • Latest data reveals that GeneDx Holdings reported Current Assets of $237.6 million as of Q3 2025, which was up 15.99% from $204.8 million recorded in Q2 2025.
  • GeneDx Holdings' 5-year Current Assets high stood at $538.5 million for Q3 2021, and its period low was $99.0 million during Q2 2021.
  • For the 3-year period, GeneDx Holdings' Current Assets averaged around $201.6 million, with its median value being $198.0 million (2024).
  • In the last 5 years, GeneDx Holdings' Current Assets surged by 36,647.87% in 2021 and then tumbled by 56.03% in 2022.
  • Quarterly analysis of 5 years shows GeneDx Holdings' Current Assets stood at $483.5 million in 2021, then tumbled by 56.03% to $212.6 million in 2022, then fell by 14.24% to $182.3 million in 2023, then grew by 8.57% to $198.0 million in 2024, then increased by 27.73% to $237.6 million in 2025.
  • Its last three reported values are $237.6 million in Q3 2025, $204.8 million for Q2 2025, and $225.8 million during Q1 2025.